McKesson's Precision Care Companion initiative enhances biomarker testing and targeted therapies in community oncology, improving patient outcomes and cost efficiency.
Suzzette Arnal, PhD
Advertisement
Articles by Suzzette Arnal, PhD
Advertisement
Latest Updated Articles
Bridging the Gap Between Biomarker Testing and Treatment in Community OncologyPublished: December 3rd 2025 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Virtual Reality Intervention Increased Empathy for Patients With MG
2
ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care
3
Mental Health Distress in Nonmelanoma Skin Cancer Largely Driven by Sociodemographic, Comorbid Factors
4
Strong Patient–Doctor Communication Improves Glaucoma Care: Ariana Levin, MD
5
